KAITLYN YOST: Open Payments
NPI 1851731939 · POTTSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 55 payments from 14 companies in 2025. Trend: 2023 $964 · 2024 $663 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $181 |
| AstraZeneca Pharmaceuticals LP | 11 | $174 |
| Lilly USA, LLC | 7 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $137 |
| PFIZER INC. | 4 | $70 |
| Abbott Laboratories | 3 | $63 |
| ABBVIE INC. | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Amgen Inc. | 2 | $31 |
| Lundbeck LLC | 1 | $29 |
Products named: CAPLYTA, Ozempic, MOUNJARO, AIRSUPRA, JARDIANCE, FREESTYLE LIBRE 3, FARXIGA, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
